Search results for "controlled"

showing 10 items of 2729 documents

Root Canal Morphology and Configuration of the Mandibular Canine: A Systematic Review

2021

The aim of this study was to systematically review the root canal morphology and configuration (RCC) of mandibular canines (MaCa). The review was registered in the PROSPERO database (ID-272297) and it was carried out following the PRISMA guidelines. Three electronic databases (MEDLINE via PubMed, Embase, Scopus) were searched. Randomized controlled trials, cross-sectional, cohort, comparative, evaluation and validation studies have been included. The anatomical quality assessment (AQUA) tool was used for a quality assessment of the anatomical studies. Of 910 studies retrieved from the systematic search, 28 studies investigating RCCs were included. Most MaCa were single-rooted (87.9–100%), w…

Health Toxicology and Mutagenesisnumber of rootsMEDLINEDentistry610 Medicine & healthMandibleReviewlaw.inventionnumber of canalsMandibular canineRandomized controlled trialmandibular caninelawHumansMedicineTooth Root610 Medicine & healthbusiness.industryQuality assessmentRPublic Health Environmental and Occupational HealthRoot canal morphologyinternal morphologyRoot Canal TherapyCross-Sectional StudiesCohortMedicineDental Pulp Cavityroot canal configurationbusinessSystematic searchInternational Journal of Environmental Research and Public Health
researchProduct

Charting a Roadmap for Heart Failure Biomarker Studies

2013

Heart failure is a syndrome with a pathophysiological basis that can be traced to dysfunction in several interconnected molecular pathways. Identification of biomarkers of heart failure that allow measurement of the disease on a molecular level has resulted in enthusiasm for their use in prognostication and selection of appropriate therapies. However, despite considerable amounts of information available on numerous biomarkers, inconsistent research methodologies and lack of clinical correlations have made bench-to-bedside translations rare and left the literature with countless publications of varied quality. There is a need for a systematic and collaborative approach aimed at definitively…

Heart FailureResearch designmedicine.medical_specialtyPathologybusiness.industryDiseasePrognosismedicine.diseaseArticlelaw.inventionClinical trialMolecular levelRandomized controlled trialResearch DesignlawHeart failuremedicineHumansBiomarker (medicine)Cooperative BehaviorBiomarker discoveryCardiology and Cardiovascular MedicinebusinessIntensive care medicineBiomarkersJACC: Heart Failure
researchProduct

Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: Let's leave the doubts behind

2020

Heart Failuremedicine.medical_specialtybusiness.industrymedicine.diseaseRenin-Angiotensin SystemInternal medicineHeart failureCardiologyHumansMedicineNeprilysinCardiology and Cardiovascular MedicinebusinessNeprilysinRandomized Controlled Trials as TopicInternational Journal of Cardiology
researchProduct

Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment

1999

Interferon alfa (IFN-alpha) is the primary treatment for chronic hepatitis B. The standard duration of IFN-alpha therapy is considered 16 weeks; however, the optimal treatment length is still poorly defined. We evaluated the efficacy and acceptability of prolonged IFN-alpha treatment in patients with chronic hepatitis B. To investigate whether treatment prolongation could enhance the rate of hepatitis B e antigen (HBeAg) seroconversion, we conducted a prospective, controlled, multicenter trial in which all patients were treated with a standard regimen of 10 million units IFN-alpha 3 times per week over 16 weeks. Patients who were still HBeAg-positive after 16 weeks of therapy were randomize…

Hepatitis B virusmedicine.medical_specialtyHepatologybusiness.industryAlpha interferonHepatitis Bmedicine.diseasemedicine.disease_causeGastroenterologySurgerylaw.inventionRegimenRandomized controlled trialHBeAglawInternal medicineMulticenter trialmedicinebusinessInterferon alfamedicine.drugHepatology
researchProduct

EFFICACY AND SAFETY OF OZONE THERAPY FOR PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER, RANDOMIZED CLINICAL TRIAL

2018

Background. Ozone therapy has a long history. Some studies proved that ozone therapy was useful in treatment of virus hepatitis. Objective: To evaluate the efficacy and safety of new medical ozone therapy system for the treatment of chronic hepatitis B. Method. One hundred eighty-nine patients with chronic hepatitis B were included in this open-label, phase 3 study, and randomly assigned to receive ozone autohemotherapy with experimental ozone generator TianYi (group 1) or with ozone generator Humares (group 2) or oral diammonium glycyrrhizinate capsules (group 3) in a 1:1:1 ratio for 12 weeks. The primary efficacy end point was sera HBV DNA level of less than 1×103 IU/ml or having a more t…

Hepatitismedicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationPhases of clinical research:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseOzone therapyGastroenterologylaw.inventionAutohemotherapyRandomized controlled triallawInternal medicineUNESCO::CIENCIAS MÉDICASmedicineClinical endpointbusinesseducationAdverse effectJournal of Ozone Therapy
researchProduct

Imaging-guided interventions modulating portal venous flow: Evidence and controversies

2021

Portal hypertension is defined by an increase in the portosystemic venous gradient. In most cases, increased resistance to portal blood flow is the initial cause of elevated portal pressure. More than 90% of cases of portal hypertension are estimated to be due to advanced chronic liver disease or cirrhosis. Transjugular intrahepatic portosystemic shunts, a non-pharmacological treatment for portal hypertension, involve the placement of a stent between the portal vein and the hepatic vein or inferior vena cava which helps bypass hepatic resistance. Portal hypertension may also be a result of extrahepatic portal vein thrombosis or compression. In these cases, percutaneous portal vein recanalis…

HepatologyGastroenterologyInternal MedicineImmunology and AllergyALPPS associating liver partition and portal vein ligation for staged hepatectomy transjugular intrahepatic portosystemic shunt BSG British Society of Gastroenterology EASL European Association for the Study of the Liver FLR future liver remnant HE hepatic encephalopathy NCBA N-butyl cyanoacrylate PH portal hypertension PVE portal vein embolisation PVR portal vein recanalisation TIPS transjugular intrahepatic portosystemic shunt Portal vein interventions TACE trans-arterial chemoembolization portal vein recanalization RCT randomised controlled trial portal vein embolization portal hypertension image guidedJHEP Reports
researchProduct

La iconografía en la era digital: hacia una heurística para el estudio del contenido de las imágenes medievales

2014

Este artículo invita a reflexionar sobre la validez de la iconografía como método para describir los temas representados en las obras artísticas medievales. En esta ocasión, se ha puesto un mayor énfasis en investigar sus implicaciones epistemológicas y los sesgos que resultan del proceso de transformar las imágenes en palabras. El objetivo principal es tratar de que aflore la llamada 'brecha semántica', una especie de barrera que impide representar verbalmente un medio no léxico, como es el visual, de manera satisfactoria y sin mermas. Tras un sucinto recorrido por el pensamiento griego, con un especial interés por la écfrasis, se sugiere que el aparente equilibrio entre las capacidades se…

HistoryMedieval artUNESCO::CIENCIAS DE LAS ARTES Y LAS LETRASHistoryLiterature and Literary TheoryPanoramaFilologíasRepresentation (arts)Otras filologías modernasIconography; Medieval Art; Middle Ages; image-text relationship; ekphrasis; digital collections; iconographic indexing; thesauriVisual artsControlled vocabulary:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]Rhetorical questionIconographyRivalrySemantic gapDigital humanitiesMagnificat Cultura i Literatura Medievals
researchProduct

Phase 3 randomized study of adjuvant anastrozole (A), exemestane (E), or letrozole (L) with or without tamoxifen (T) in postmenopausal women with hor…

2017

515 Background: Uncertainty still exists regarding the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors (AI) and no trial has ever compared all the three AI. Methods: FATA-GIM3 is a multicenter, open label, 2x3 factorial phase 3 randomized study of adjuvant A, E and L upfront (UP - for 5 years) or sequentially (SEQ - for 3 years after 2 years of T) in postmenopausal HR breast cancer pts. Two comparisons were planned: UP vs SEQ and A vs E vs L. DFS (including local or distant relapse, second breast or non-breast cancer, DCIS and death, whichever came first) was the primary end-point; 2% at 5 yrs (corresponding to a HR of 0.79) was defined as the minimum diff…

Hormone ResponsiveOncologyCancer Researchmedicine.medical_specialtymedicine.medical_treatmentAnastrozolelaw.invention03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBreast cancerRandomized controlled trialExemestanelawInternal medicinemedicineData monitoring committeeGynecologybusiness.industryLetrozoleCancerHematologymedicine.diseaseOncologychemistry030220 oncology & carcinogenesisbusinessAdjuvantTamoxifen030215 immunologymedicine.drugJournal of Clinical Oncology
researchProduct

Avoiding Bias in Observational Studies

2009

Background Many questions in human health research can only be answered with observational studies. In contrast to controlled experiments or well-planned, experimental randomized clinical trials, observational studies are subject to a number of potential problems that may bias their results.

Human healthmedicine.medical_specialtyRandomized controlled trialbusiness.industrylawMedicineObservational studyMedical physicsGeneral MedicinePublication biasbusinesslaw.inventionDeutsches Ärzteblatt international
researchProduct

Discrimination in the sharing economy: evidence from a hungarian field experiment on the topic of ridesharing

2018

This paper describes small-scale experimental research (total N=160) implemented in Hungary in summer 2017 by TÁRKI, the Hungarian Social Research Centre. The research was based on a controlled field experimental design and examined the chances of ethnically different testers being offered rides on the most well-known international ridesharing platform. The creation of eight experimental profiles enabled us to test the interaction between two experimental stimuli: ethnic/racial background and gender. The present paper provides evidence of ethnic/racial disproportionality in offers of rides to the different testers by multiethnic drivers. A large-size effect was detected in the case of the A…

Hungarycontrolled field experimentsharing economyridesharingdiscriminationCorvinus Journal of Sociology and Social Policy
researchProduct